Diabetes and hepatocellular cancer risk: Not only a matter of hyperglycemia

Patients With NASH and Cryptogenic Cirrhosis Are Less Likely Than Those With Hepatitis C to Receive Liver Transplants

(2011) Jacqueline G. O'Leary et al.   Clinical Gastroenterology and Hepatology

Risk of Bladder Cancer Among Diabetic Patients Treated With Pioglitazone: Interim report of a longitudinal cohort study

(2011) J. D. Lewis et al.   DIABETES CARE

Diabetes mellitus and risk of hepatocellular carcinoma: a systematic review and meta-analysis

(2011) Ping Wang et al.   DIABETES-METABOLISM RESEARCH AND REVIEWS

Metabolic syndrome increases the risk of primary liver cancer in the United States: A study in the SEER-medicare database

(2011) Tania M. Welzel et al.   HEPATOLOGY

Exenatide in the Treatment of Diabetic Patients With Non-Alcoholic Steatohepatitis: A Case Series

(2010) Patrick R Kenny et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

Sitagliptin prevents the development of metabolic and hormonal disturbances, increased β-cell apoptosis and liver steatosis induced by a fructose-rich diet in normal rats

(2010) Bárbara Maiztegui et al.   CLINICAL SCIENCE

Does diabetes therapy influence the risk of cancer?

(2009) U. Smith et al.   DIABETOLOGIA

Antidiabetic therapy and increased risk of hepatocellular carcinoma in chronic liver disease

(2009) Valter Donadon et al.   WORLD JOURNAL OF GASTROENTEROLOGY